This study aimed to determine whether receptors for endothelin were present on the cardiac myocyte as well as on vascular smooth muscle cells. Low-and high-resolution autoradiography was performed using`251-endothelin 1 on intact rat myocardium and samples of human ventricle obtained from explanted hearts at the time of transplant. In addition to specific binding to the smooth muscle of the blood vessel lumen, there was considerable binding associated with cardiac myocytes. To discover whether there was any functional correlate for this binding, muscle cells were isolated enzymatically from human and rat ventricle and from rat femoral artery, and their contractile characteristics were studied. Single cardiac cells were superfused with physiological saline at 320 C, and their length change was displayed continuously on a chart recorder. Endothelin 1 had a pronounced effect on shortening in both rat and human myocytes. The contraction amplitude was approximately doubled in both cases, from 4.1±0.8% cell length to 8.1±1.3% for rat (mean±SEM, n=9,p<0.001), and from 2.1±0.5% to 4.0±0.5% in human (n = 10, p <0.001). In rat, the magnitude of the effect was comparable to that of the ca-adrenoceptor agonist phenylephrine. The maximum contraction amplitude of the human cells, produced by raising extracellular calcium to greater than 10 mM, was 11.4±1.1% cell length (n=9), significantly greater than that produced by endothelin (p<0.001). The threshold for the effect of endothelin 1 was around 0.3 nM, and maximum effects were attained at 30 nM, compared with 1 and 100 ,uM, respectively, for the a-adrenoceptor effect. Endothelin 1 had a potent action on single vascular smooth muscle cells. The EC50 for endothelin 1 was 36±4 pM (n=8) compared with 3.0±1.6 ,uM (n=7) 27, 1989; accepted April 10, 1990. endothelin binding sites has been demonstrated in human coronary vessels using in vitro autoradiography.2 This binding is associated mainly with the smooth muscle, with some binding to perivascular structures.2 There is recent evidence that, apart from its constrictor action, endothelin has both positive inotropic and chronotropic effects on the heart.3-5 The purpose of this study was to use high-and low-resolution autoradiography to determine whether P1-endothelin 1 binding sites are present on cardiomyocytes and to establish the functional relevance of such sites using isolated myocytes prepared from human and rat heart. The contractile properties of
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The purpose of this study was to use high-and low-resolution autoradiography to determine whether P1-endothelin 1 binding sites are present on cardiomyocytes and to establish the functional relevance of such sites using isolated myocytes prepared from human and rat heart. The contractile properties of cardiac muscle cells exposed to endothelin 1 were compared with those of single arterial wall smooth muscle cells. The effects of a-adrenoceptor agonists, which also combine vasoconstrictor and positive inotropic actions, were determined in parallel with those of endothelin 1 on both cell types.
Methods

In Vitro Autoradiography
The in vitro autoradiographic technique used for this study was essentially that described by Young and Kuhar,6 with modifications for vascular tissue.7 Ventricular tissue, obtained from patients undergoing heart transplantation (n =7), was frozen in isopentane or on solid CO2 (Distillers Mg. Ltd., Surrey, U.K.) and stored at -70°C. Hearts were removed from male rats (200 g) killed by cervical dislocation and were frozen on solid CO2. 
High-Resolution Studies
Slide-mounted sections (10 ,um) were postfixed by exposure to paraformaldehyde vapor (800C for 2 hours) in an evacuated dessicator. Sections were then defatted by two Histoclear (National Diagnostics, Inc., Bucks, U.K.) washes and a series of aqueous ethanol (100-70%) washes followed by washing in glassdistilled water. Slides were then dipped individually into molten nuclear emulsion (Ilford, K2 diluted 1:1 with 2% glycerol in glass-distilled water) and allowed to dry for several hours at room temperature. Slides were stored in lightproof boxes containing silica gel for 10-21 days at 40 C before being developed in D19 (Kodak, undiluted) for 5 minutes at 200 C, dipped in 1% acetic acid, and fixed in Hypam (Ilford, diluted 1:4 with glass-distilled water) for 2 minutes. Sections were then washed in four changes of glass-distilled water for 30 minutes, stained with Mayer's hemotoxylin, and coverslipped. Sections and autoradiographs were viewed under dark and bright field illumination on an Olympus Vanox microscope and photographed where appropriate. In some instances, tissue used for low-resolution autoradiography (i.e., that exposed to Hyperfilm) was postfixed and reprocessed for highresolution autoradiography as described above.
Isolation of Cardiac Myocytes
Myocytes were isolated from Langendorff-perfused rat heart as previously described.8 Tissue was obtained from explanted human heart at the time of transplant, cut into chunks of approximately 1 mm3 using razors, and shaken in 25-50 ml of a lowcalcium medium composed of (mM) NaCl 120, KCl Rat + phanylephrine Rat + endothelin Human + ondothelin muscle and show that, as with the smooth muscle, the effect is not endothelium dependent. The percentage changes in contraction amplitude induced by endothelin in the single cardiac cells are considerably greater than those of tension in whole muscle. Amplitude was doubled in both rat and human cells, whereas the reported increases in papillary muscle tension were only 17.1% and 9.9%, respectively.5 Concentrations used were similar -50 nM on whole muscle5 compared with the 30 nM maximum in this study. It has been noted that removal of endothelium can increase the apparent effect of endothelin in rabbit femoral arteries, suggesting that the endothelium may form a barrier to the passage of exogenously added endothelin in isolated whole muscle preparations.14 It may be that the sheath of endothelium surrounding papillary muscles also limits the action of endothelin, causing the discrepancy in effectiveness between cells and whole muscle. Alternatively, the sheath of endothelium may be releasing endothelin tonically, obscuring the effect of the exogenous addition. The differences could also be due to the fact that the whole muscle was contracting isometrically, whereas the single cells were unloaded.
The response of rat myocytes to endothelin was similar in magnitude to that produced by the aadrenoceptor agonist, phenylephrine, and considerably smaller than that to high calcium. We have previously shown that 13-adrenoceptor agonists produce maximum contraction amplitudes approximately equivalent to those of calcium in rat, rabbit, and human myocytes.815 Endothelin and phenylephrine are also alike in that they do not accelerate shortening or relaxation. In contrast, ,-adrenoceptor agonists speed these parameters in both rat and human cells.8 '5 These results are consistent with suggestions that both endothelin and phenylephrine produce their results through an increase in inositol trisphosphate rather than cyclic AMP.11, [16] [17] [18] Is the positive inotropic effect of endothelin likely to contribute significantly to heart force under physiological conditions? Endothelin does not begin to have an effect on the cardiac myocyte until a concentration of 0.3 nM is reached, 10-fold higher than its EC50 on vascular muscle. It is unknown whether sufficiently high levels would be reached in the vicinity of the cardiac muscle cells in vivo. Furthermore, the magnitude of the effect of endothelin is small. However, it has been suggested that the similarly sized effect of a-agonists can become important in maintaining heart force when 1-adrenoceptors are desensitized.'8 Endothelin may therefore make a contribution to heart force under circumstances in which other inotropic mechanisms are inoperative. It is possible that the small, irreversible decrease in force that occurs when isolated papillary muscle endothelium is selectively damaged19 may be due to a reduction in the endothelin concentration at the cardiac myocyte.
